| For: | Li YQ, Tao KS, Ren N, Wang YH. Effect of c-fos antisense probe on prostaglandin E2 -induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells. World J Gastroenterol 2005; 11(28): 4427-4430 [PMID: 16038047 DOI: 10.3748/wjg.v11.i28.4427] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i28/4427.htm |
| Number | Citing Articles |
| 1 |
Li Zhang, Xiaoxin Li, Mingwei Zhao, Peiying He, Weidong Yu, Jianqiang Dong, Guodong Liu, Chunan Li, Xuan Shi. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation; a key step in the progression of proliferative vitreoretinopathy. Experimental Eye Research 2006; 83(6) doi: 10.1016/j.exer.2006.07.020
|
| 2 |
L Oliveira-Ferrer, K Rößler, V Haustein, C Schröder, D Wicklein, D Maltseva, N Khaustova, T Samatov, A Tonevitsky, S Mahner, F Jänicke, U Schumacher, K Milde-Langosch. c-FOS suppresses ovarian cancer progression by changing adhesion. British Journal of Cancer 2014; 110(3) doi: 10.1038/bjc.2013.774
|
| 3 |
Grzegorz Korpanty, Laura A. Sullivan, Elizabeth Smyth, Desmond N. Carney, Rolf A. Brekken. Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors. Journal of Oncology 2010; 2010 doi: 10.1155/2010/652320
|
| 4 |
Elisavet Serti, Polyxeni P. Doumba, George Thyphronitis, Panagiota Tsitoura, Konstantina Katsarou, Pelagia Foka, Manousos M. Konstandoulakis, John Koskinas, Penelope Mavromara, Urania Georgopoulou. Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cellular and Molecular Life Sciences 2011; 68(3) doi: 10.1007/s00018-010-0466-8
|
| 5 |
Xingya Wang, Russell D. Klein. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor‐mediated cAMP pathway. Molecular Carcinogenesis 2007; 46(11) doi: 10.1002/mc.20320
|
| 6 |
Jung-Ae Kim, Kyoung Bin Cho, Mi Ra Kim, Byung Chul Park, Sang Kyum Kim, Moo Yeol Lee, Keon Wook Kang. Decreased production of vascular endothelial growth factor in adriamycin-resistant breast cancer cells. Cancer Letters 2008; 268(2) doi: 10.1016/j.canlet.2008.03.050
|
| 7 |
Paul J. Davis, Thangirala Sudha, Hung‐Yun Lin, Shaker A. Mousa. Thyroid Hormone, Hormone Analogs, and Angiogenesis. Comprehensive Physiology 2016; 6(1) doi: 10.1002/j.2040-4603.2016.tb00679.x
|
| 8 |
Dingding Han, Penggao Yang, Bo Qin, Guoqing Ji, Yanhua Wu, Long Yu, Hong Zhang. Upregulation of Nogo‐B by hypoxia inducible factor‐1 and activator protein‐1 in hepatocellular carcinoma. Cancer Science 2021; 112(7) doi: 10.1111/cas.14941
|
| 9 |
Konstantina Katsarou, Alexandros Α. Lavdas, Panagiota Tsitoura, Elisavet Serti, Panagiotis Markoulatos, Penelope Mavromara, Urania Georgopoulou. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK–ERK1/2 signaling events. Cellular and Molecular Life Sciences 2010; 67(14) doi: 10.1007/s00018-010-0351-5
|
| 10 |
Paul J. Davis, Shaker A. Mousa. Anti-Angiogenesis Strategies in Cancer Therapeutics. 2017; doi: 10.1016/B978-0-12-802576-5.00009-7
|
| 11 |
Paul J. Davis, Thangirala Sudha, Hung‐Yun Lin, Shaker A. Mousa. Comprehensive Physiology. 2015; doi: 10.1002/cphy.c150011
|
| 12 |
Mi Ra Kim, Hong Seok Choi, Tae-Hwe Heo, Sun Wook Hwang, Keon Wook Kang. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochemical and Biophysical Research Communications 2008; 369(2) doi: 10.1016/j.bbrc.2008.02.045
|
| 13 |
Tae-Joon Park, Jeong-Hyun Kim, Byung-Lae Park, Joon Seol Bae, Hyun Sub Cheong, Charisse Flerida Pasaje, Hyo Suk Lee, Yoon Jun Kim, Hyoung Doo Shin. Lack of association between FOS polymorphisms and clearance of HBV infection as well as HCC occurrence. Genes & Genomics 2011; 33(4) doi: 10.1007/s13258-010-0179-2
|
| 14 |
Mi Ra Kim, Hong Seok Choi, Jin Won Yang, Byung Chul Park, Jung-Ae Kim, Keon Wook Kang. Enhancement of vascular endothelial growth factor–mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression. Molecular Cancer Therapeutics 2009; 8(8) doi: 10.1158/1535-7163.MCT-08-1061
|